Stephen W. Kidder’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.25M Buy
14,603
+1,887
+15% +$836K 1.83% 20
2026
Q1
$5.68M Buy
12,716
+257
+2% +$120K 1.67% 24
2025
Q4
$5.65M Buy
12,459
+161
+1% +$69.4K 1.59% 22
2025
Q3
$4.82M Buy
12,298
+168
+1% +$70.2K 1.38% 24
2025
Q2
$5.4M Buy
12,130
+164
+1% +$75.6K 1.62% 24
2025
Q1
$5.8M Buy
11,966
+1,718
+17% +$801K 1.81% 25
2024
Q4
$4.13M Buy
10,248
+2,544
+33% +$1.18M 1.24% 26
2024
Q3
$3.58M Buy
7,704
+3,145
+69% +$1.51M 1.06% 29
2024
Q2
$2.14M Buy
4,559
+3,986
+696% +$1.73M 0.67% 33
2024
Q1
$240K Buy
+573
New +$242K 0.08% 68

Other funds holding VRTX

Stephen W. Kidder's VRTX Position: Q2 2026 in Review

Stephen W. Kidder increased its Vertex Pharmaceuticals (VRTX) stake by 15% in Q2 2026, buying an estimated $836K and bringing the position to 14,603 shares worth $7.25M. The position accounts for 1.83% of the portfolio, ranked #20.

Stephen W. Kidder first reported a position in VRTX in Q1 2024 and has held it in 10 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Stephen W. Kidder held 14,603 shares of Vertex Pharmaceuticals worth $7.25M as of Q2 2026.
  • Stephen W. Kidder bought 1,887 Vertex Pharmaceuticals shares in Q2 2026, an estimated $836K.
  • Vertex Pharmaceuticals made up 1.83% of Stephen W. Kidder's portfolio in Q2 2026, its #20 holding.
  • Stephen W. Kidder first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Stephen W. Kidder's 13F filing for Q2 2026, filed 21 Aug 2026.